TAK — Takeda Pharmaceutical Co Ltd
In 2026 Q2, 3 of the 140 tracked hedge funds reported a position in Takeda Pharmaceutical Co Ltd (TAK), worth $68.33M combined. Over the quarter 1 opened or added, 2 trimmed or exited.
Hedge fund holders, 2026 Q2
| Fund | Value | Portfolio % | Change |
|---|---|---|---|
| Renaissance | $41.17M | 0.06% | -14.1% |
| VanEck | $26.83M | 0.02% | -25.9% |
| Quadrature | $334.55K | 0.00% | NEW |
All stocks · Quarterly Trends · Hedge Fund Tracker
Source: SEC EDGAR 13F filings, reported as of quarter end and filed up to 45 days later. Not investment advice.